Tom J M Smeets
Overview
Explore the profile of Tom J M Smeets including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
843
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lebre M, Jongbloed S, Tas S, Smeets T, McInnes I, Tak P
Am J Pathol
. 2008 Feb;
172(4):940-50.
PMID: 18292234
Dendritic cells (DCs) have been proposed to play a pivotal role in the initiation and perpetuation of rheumatoid arthritis (RA) by presentation of arthritogenic antigens to T cells. We investigated...
2.
Wijbrandts C, Vergunst C, Haringman J, Gerlag D, Smeets T, Tak P
Arthritis Rheum
. 2007 Oct;
56(11):3869-71.
PMID: 17968928
No abstract available.
3.
Bresnihan B, Gerlag D, Rooney T, Smeets T, Wijbrandts C, Boyle D, et al.
J Rheumatol
. 2007 Mar;
34(3):620-2.
PMID: 17343309
Successive studies from one academic center (Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) have consistently suggested that synovial tissue expression of sublining macrophages may be a biomarker of...
4.
Kop E, Adriaansen J, Smeets T, Vervoordeldonk M, van Lier R, Hamann J, et al.
Arthritis Res Ther
. 2006 Sep;
8(5):R155.
PMID: 17007638
Synovial tissue of rheumatoid arthritis (RA) patients is characterised by an influx and retention of CD97-positive inflammatory cells. The ligands of CD97, CD55, chondroitin sulfate B, and alpha5beta1 (very late...
5.
Haringman J, Gerlag D, Smeets T, Baeten D, Van den Bosch F, Bresnihan B, et al.
Arthritis Rheum
. 2006 Jul;
54(8):2387-92.
PMID: 16869001
Objective: Chemokines such as CCL2/monocyte chemotactic protein 1 (MCP-1) play a key role in leukocyte migration and are potential targets in the treatment of chronic inflammatory disorders. The objective of...
6.
Haringman J, Vinkenoog M, Gerlag D, Smeets T, Zwinderman A, Tak P
Arthritis Res Ther
. 2005 Jul;
7(4):R862-7.
PMID: 15987488
Analysis of biomarkers in synovial tissue is increasingly used in the evaluation of new targeted therapies for patients with rheumatoid arthritis (RA). This study determined the intrarater and inter-rater reliability...
7.
Berckmans R, Nieuwland R, Kraan M, Schaap M, Pots D, Smeets T, et al.
Arthritis Res Ther
. 2005 May;
7(3):R536-44.
PMID: 15899040
Synovial fluid from patients with various arthritides contains procoagulant, cell-derived microparticles. Here we studied whether synovial microparticles modulate the release of chemokines and cytokines by fibroblast-like synoviocytes (FLS). Microparticles, isolated...
8.
Gerlag D, Haringman J, Smeets T, Zwinderman A, Kraan M, Laud P, et al.
Arthritis Rheum
. 2004 Dec;
50(12):3783-91.
PMID: 15593225
Objective: To create greater understanding of the changes in synovial tissue parameters that occur in conjunction with clinical response by using an effective therapy, in order to facilitate the planning...
9.
Vossenaar E, Smeets T, Kraan M, Raats J, van Venrooij W, Tak P
Arthritis Rheum
. 2004 Nov;
50(11):3485-94.
PMID: 15529392
Objective: Antibodies directed toward citrullinated proteins (e.g., anti-cyclic citrullinated peptide antibodies) are highly specific for rheumatoid arthritis (RA) and are produced locally at the site of inflammation. Although the presence...
10.
Holten J, Reedquist K, Sattonet-Roche P, Smeets T, Plater-Zyberk C, Vervoordeldonk M, et al.
Arthritis Res Ther
. 2004 May;
6(3):R239-49.
PMID: 15142270
We investigated the therapeutic potential and mechanism of action of IFN-beta protein for the treatment of rheumatoid arthritis (RA). Collagen-induced arthritis was induced in DBA/1 mice. At the first clinical...